These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1735780)
1. An oscillating bubble chamber for laboratory scale production of monoclonal antibodies as an alternative to ascitic tumours. Pannell R; Milstein C J Immunol Methods; 1992 Jan; 146(1):43-8. PubMed ID: 1735780 [TBL] [Abstract][Full Text] [Related]
2. [Production of monoclonal antibodies in serum-free medium in dialysis tubing]. Witt S; Ziegler B; Blumentritt C; Schlosser M; Ziegler M Allerg Immunol (Leipz); 1991; 37(2):67-74. PubMed ID: 1801593 [TBL] [Abstract][Full Text] [Related]
3. Laboratory scale production of monoclonal antibodies in a tumbling chamber. Jaspert R; Geske T; Teichmann A; Kassner YM; Kretzschmar K; L'age-Stehr J J Immunol Methods; 1995 Jan; 178(1):77-87. PubMed ID: 7829868 [TBL] [Abstract][Full Text] [Related]
4. A simple and inexpensive high density dialysis tubing cell culture system for the in vitro production of monoclonal antibodies in high concentration. Falkenberg FW; Hengelage T; Krane M; Bartels I; Albrecht A; Holtmeier N; Wüthrich M J Immunol Methods; 1993 Oct; 165(2):193-206. PubMed ID: 8228270 [TBL] [Abstract][Full Text] [Related]
5. Large-scale production of monoclonal antibodies in dialysis tubing. Sjögren-Jansson E; Jeansson S J Immunol Methods; 1985 Nov; 84(1-2):359-64. PubMed ID: 4067321 [TBL] [Abstract][Full Text] [Related]
6. Production of human monoclonal antibodies in dialysis tubing. Sjögren-Jansson E; Ohlin M; Borrebaeck CA; Jeansson S Hybridoma; 1991 Jun; 10(3):411-9. PubMed ID: 1916852 [TBL] [Abstract][Full Text] [Related]
7. Dialysis-based bioreactor systems for the production of monoclonal antibodies--alternatives to ascites production in mice. Bruce MP; Boyd V; Duch C; White JR J Immunol Methods; 2002 Jun; 264(1-2):59-68. PubMed ID: 12191510 [TBL] [Abstract][Full Text] [Related]
8. Increase of hybridoma productivity using an original dialysis culture system. Mathiot B; Perani A; Dumas D; Maugras M; Didelon J; Stoltz JF Cytotechnology; 1993; 11(1):41-8. PubMed ID: 7763635 [TBL] [Abstract][Full Text] [Related]
9. Efficient laboratory-scale production of monoclonal antibodies using membrane-based high-density cell culture technology. Trebak M; Chong JM; Herlyn D; Speicher DW J Immunol Methods; 1999 Nov; 230(1-2):59-70. PubMed ID: 10594354 [TBL] [Abstract][Full Text] [Related]
10. A hollow fibre dialysis system for the in vitro production of monoclonal antibodies replacing in vivo production in mice. Schönherr OT; van Gelder PT; van Hees PJ; van Os AM; Roelofs HW Dev Biol Stand; 1987; 66():211-20. PubMed ID: 3582749 [TBL] [Abstract][Full Text] [Related]
11. Hybridoma antibody production in vitro in type II serum-free medium using Nutridoma-SP supplements. Comparisons with in vivo methods. Federspiel G; McCullough KC; Kihm U J Immunol Methods; 1991 Dec; 145(1-2):213-21. PubMed ID: 1765654 [TBL] [Abstract][Full Text] [Related]
12. Bovine colostrum ultrafiltrate: an effective supplement for the culture of mouse-mouse hybridoma cells. Pakkanen R; Neutra M J Immunol Methods; 1994 Feb; 169(1):63-71. PubMed ID: 8133074 [TBL] [Abstract][Full Text] [Related]
13. Selective generation of antigen-specific human hybridomas optimized for large scale growth in serum-free medium. Lang AB; Schürch U; Zimmermann F; Bruderer U J Immunol Methods; 1992 Sep; 154(1):21-6. PubMed ID: 1401940 [TBL] [Abstract][Full Text] [Related]
14. Continuous production of large amounts of monoclonal immunoglobulins in hollow fibers using protein-free medium. Dhainaut F; Bihoreau N; Meterreau JL; Lirochon J; Vincentelli R; Mignot G Cytotechnology; 1992; 10(1):33-41. PubMed ID: 1369103 [TBL] [Abstract][Full Text] [Related]
15. Considerations for in vitro monoclonal antibody production. Peterson NC Res Immunol; 1998; 149(6):553-7. PubMed ID: 9835417 [No Abstract] [Full Text] [Related]
16. Hybridoma growth and monoclonal antibody production in iron-rich protein-free medium: effect of nutrient concentration. Franĕk F; Dolníková J Cytotechnology; 1991 Sep; 7(1):33-8. PubMed ID: 1367699 [TBL] [Abstract][Full Text] [Related]
17. Human, rat or mouse hybridomas secrete high levels of monoclonal antibodies following transplantation into mice with severe combined immunodeficiency disease (SCID). Ware CF; Donato NJ; Dorshkind K J Immunol Methods; 1985 Dec; 85(2):353-61. PubMed ID: 4078317 [TBL] [Abstract][Full Text] [Related]
18. A self-feeding roller bottle for continuous cell culture. Berson RE; Friederichs G Biotechnol Prog; 2008; 24(1):154-7. PubMed ID: 18171073 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody production in murine ascites. II. Production characteristics. Jackson LR; Trudel LJ; Fox JG; Lipman NS Lab Anim Sci; 1999 Feb; 49(1):81-6. PubMed ID: 10090099 [TBL] [Abstract][Full Text] [Related]
20. Effect of alpha-ketoglutarate on monoclonal antibody production of hybridoma cell lines in serum-free and serum-containing medium. Nilsang S; Kumar A; Rakshit SK Appl Biochem Biotechnol; 2008 Dec; 151(2-3):489-501. PubMed ID: 18696264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]